Open access · CC-BY
via OpenAlex
Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study
Yue-Yu Gu, Min Zhang, Huan Cen, Yi-Fan Wu, Zhaoyu Lu, Fuhua Lu, Xu-Sheng Liu, Hui-Yao Lan
PLoS ONE · 2021 · ▲ 76 citations
Abstract
Kidneys are one of the targets for SARS-CoV-2, it is reported that up to 36% of patients with SARS-CoV-2 infection would develop into acute kidney injury (AKI). AKI is associated with high mortality in the clinical setting and contributes to the transition of AKI to chronic kidney disease (CKD). Up to date, the underlying mechanisms are obscure and there is no effective and specific treatment for COVID-19-induced AKI. In the present study, we investigated the mechanisms and interactions between Quercetin and SARS-CoV-2 targets proteins by using network pharmacology and molecular docking. The renal protective effects of Quercetin on COVID-19-induced AKI may be associated with the blockade of the activation of inflammatory, cell apoptosis-related signaling pathways. Quercetin may also serve as SARS-CoV-2 inhibitor by binding with the active sites of SARS-CoV-2 main protease 3CL and ACE2, therefore suppressing the functions of the proteins to cut the viral life cycle. In conclusion, Quercetin may be a novel therapeutic agent for COVID-19-induced AKI. Inhibition of inflammatory, cell apoptosis-related signaling pathways may be the critical mechanisms by which Quercetin protects kidney from SARS-CoV-2 injury.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0245209
- Canonical
- link ↗
- Fetched
- 2026-09-06 MST
Cite this
APA
Gu, Y., Zhang, M., Cen, H., Wu, Y., Lu, Z., Lu, F., Liu, X., & Lan, H. (2021). Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0245209
Vancouver
Gu Y, Zhang M, Cen H, Wu Y, Lu Z, Lu F, et al. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. PLoS ONE. 2021. doi:10.1371/journal.pone.0245209.
BibTeX
@article{yueyu2021Querce,
title = {Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study},
author = {Yue-Yu Gu and Min Zhang and Huan Cen and Yi-Fan Wu and Zhaoyu Lu and Fuhua Lu and Xu-Sheng Liu and Hui-Yao Lan},
journal = {PLoS ONE},
year = {2021},
doi = {10.1371/journal.pone.0245209},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Journal of Immunology 2008
Open access · OA
IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease
International Journal of Molecular Sciences 2020
Open access · CC-BY
The Role of Sirtuins in Kidney Diseases
Pharmaceutics 2021
Open access · CC-BY
Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
Stem cell research & therapy 2026
Citation only
Neuroprotective effect of mesenchymal stem cell-derived miR-143-3p on dopaminergic neurons via the TLR3/NF-κB/p53 signaling pathway.
International Journal of Molecular Sciences 2018
Open access · CC-BY
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Journal of the American Geriatrics Society 2015
Open access · OA